Tuesday, November 24, 2009, 9:40pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Salix Pharmaceuticals Ltd. (SLXP)

 At 16:00 EST: 23.56 USD  Up 0.10 (0.43%)  
MORE ON SLXP
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Salix Pharmaceuticals, Ltd. (NasdaqNM:SLXP) Delayed quote dataEdit
After Hours: 23.56 Down 0.00 (0.02%) as of 4:15pm EST on 11/24/09
Last Trade: 23.56 USD
Trade Time: 4:00PM EST
Change: Up 0.10 (0.43%)
Prev Close: 23.46
Open: 23.62
Bid: 22.85 x 100
Ask: 24.18 x 100
1y Target Est: 8.50
Day's Range: 22.99 - 23.86
52wk Range: 6.14 - 24.29
Volume: 639,764
Avg Vol (3m): 1,000,120
Market Cap: 1.16B
P/E (ttm): 27.85
EPS (ttm): 0.85
Div & Yield: N/A (N/A%)
Salix Pharmaceuticals Ltd. (SLXP)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add SLXP to Portfolio   Download Data

HEADLINES
• SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue 2:43pm)
• Salix Pharmaceuticals to Present at Piper Jaffray Conference
Business Wire (Tue 7:05am)
• Salix Pharmaceuticals completes stock offering
AP (Mon 2:45pm)
• SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibi
EDGAR Online (Mon 1:12pm)
• Salix pockets $128.2M in stock offering
at bizjournals.com (Mon 1:05pm)
• Salix Pharmaceuticals, Ltd. Completes Sale of 6.325 Million Shares of Common Stock
Business Wire (Mon 11:50am)
• SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibi
EDGAR Online (Thu, Nov 19)
• Build Your Fortune With These Winners
at Motley Fool (Wed, Nov 18)
• Salix offering 5.5 million shares of stock
AP (Wed, Nov 18)
• Salix Pharmaceuticals, Ltd. Announces Pricing of a Public Offering of Common Stock
Business Wire (Wed, Nov 18)
More Headlines for SLXP...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : 0.11
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Salix Pharmaceuticals, Ltd. engages in acquiring, developing, and commercializing prescription drugs used in the treatment of various gastrointestinal diseases in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices